Certara Reports First Quarter 2025 Financial Results
RADNOR, PA— 2025年5月5日-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development,…
Certara2025年5月5日
Rare disease drug development: challenges, support and hopes for the future
Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…
Certara2025年4月29日
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions
Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…
Certara2025年4月24日
Certara Announces Second Annual Certainty U.S. Event
Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…
Certara2025年4月22日
Using cost-effectiveness models for smarter drug development and healthcare decisions
2025年4月14日 Editor’s note: This is the second in a series of four articles…
Certara2025年4月14日
FDA to phase out animal testing with AI and lab-based models
FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…
Certara2025年4月11日
Delivering DSUR Excellence for Multinational Biopharma
A global leader in immuno-oncology approached us for support with over 50 simple to complex…
Certara2025年4月11日
FDA plans to phase out animal testing requirements
Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…
Certara2025年4月10日
Standardizing Real World Data in Rare Disease: ATHN’s Journey
Learn how Certara helped ATHN standardize Real World Data for regulatory submissions, advancing rare disease…
Certara2025年4月8日
